The Kroger Co. is a major U.S. retailer operating a wide array of store formats, including combination food and drug stores, multi-department stores, and marketplace stores, complemented by price impact warehouse stores. The company also engages in food manufacturing and processing, and operates fuel centers, positioning itself as a comprehensive provider of consumer goods within the Consumer Defensive sector, specifically the Grocery Stores industry. In its most recent reported quarters, Kroger demonstrated a pattern of exceeding earnings per share estimates. For Q2 2025, actual EPS of $1.04 surpassed the estimate of $0.99762, and for Q3 2025, actual EPS of $1.05 exceeded the estimate of $1.0326. This follows a strong Q1 2025 where actual EPS of $1.49 beat the estimate of $1.45747, and a Q4 2024 where actual EPS of $1.14 exceeded the estimate of $1.11241. Revenue figures are available for Q4 2024 ($34.308 billion) and Q1 2025 ($45.118 billion), though estimates were not provided for these periods. The company has shown consistent EPS beats in the last four reported quarters for which data is available, indicating a reliable performance against analyst expectations. While revenue estimates were not consistently provided, the actual revenue figures for the earlier quarters suggest a significant increase from Q4 2024 to Q1 2025, followed by a decrease in Q2 2025 and a slight dip in Q3 2025, indicating some quarterly fluctuations. Recent news highlights Kroger's strategic moves, including the upgrade of its Relative Strength Rating to 82, reflecting improved market leadership. The company is expanding its pharmacy services by offering Eli Lilly's Zepbound KwikPen, aiming to capitalize on the demand for weight-management therapies. However, Kroger is also planning to close approximately 50 Little Clinic locations as part of a business simplification strategy. Investors will be watching for how these pharmacy expansions and clinic closures impact overall profitability and market positioning in the upcoming quarters, as well as the continued execution of operational efficiencies and cost reductions that have contributed to improved gross margins.
